SCHOLAR ROCK HLDG CORP's ticker is SRRK and the CUSIP is 80706P103. A total of 105 filers reported holding SCHOLAR ROCK HLDG CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $152,481 | +3592.0% | 20,223 | -96.1% | 0.00% | -100.0% |
Q1 2023 | $4,130 | +313.4% | 516,247 | +367.7% | 0.00% | +100.0% |
Q4 2022 | $999 | -99.9% | 110,384 | -37.8% | 0.00% | 0.0% |
Q3 2022 | $1,229,000 | -76.2% | 177,327 | -81.1% | 0.00% | -66.7% |
Q2 2022 | $5,160,000 | +6.9% | 939,895 | +150.9% | 0.00% | 0.0% |
Q1 2022 | $4,829,000 | +193.6% | 374,601 | +465.8% | 0.00% | +200.0% |
Q4 2021 | $1,645,000 | -35.6% | 66,212 | -14.4% | 0.00% | -50.0% |
Q3 2021 | $2,554,000 | -49.2% | 77,348 | -55.5% | 0.00% | -33.3% |
Q2 2021 | $5,024,000 | +142.6% | 173,839 | +325.2% | 0.00% | +200.0% |
Q1 2021 | $2,071,000 | -71.3% | 40,883 | -72.5% | 0.00% | -80.0% |
Q4 2020 | $7,214,000 | +275.5% | 148,659 | +40.9% | 0.01% | +66.7% |
Q2 2020 | $1,921,000 | +1071.3% | 105,489 | +746.0% | 0.00% | – |
Q4 2019 | $164,000 | -54.8% | 12,469 | -69.3% | 0.00% | -100.0% |
Q3 2019 | $363,000 | -59.5% | 40,609 | +4.1% | 0.00% | 0.0% |
Q4 2018 | $896,000 | -33.6% | 39,012 | -54.9% | 0.00% | -50.0% |
Q2 2018 | $1,349,000 | – | 86,456 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Artal Group S.A. | 2,450,000 | $31,581,000 | 1.32% |
Logos Global Management LP | 675,000 | $8,701,000 | 1.13% |
Samsara BioCapital, LLC | 339,611 | $4,378,000 | 1.10% |
Redmile Group, LLC | 2,407,326 | $31,030,000 | 0.97% |
Bellevue Group AG | 2,184,425 | $28,157,000 | 0.33% |
Frazier Life Sciences Management, L.P. | 156,000 | $2,011,000 | 0.17% |
Atom Investors LP | 25,839 | $333,000 | 0.16% |
GSA CAPITAL PARTNERS LLP | 32,010 | $413,000 | 0.06% |
Tekla Capital Management LLC | 108,833 | $1,403,000 | 0.05% |
Virtus ETF Advisers LLC | 6,212 | $80,000 | 0.04% |